Effect of Tranexamic Acid on Hidden Blood Loss in Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion: A Retrospective Study
DOI: https://doi.org/10.2147/tcrm.s462784
2024-05-29
Therapeutics and Clinical Risk Management
Abstract:Yanlei Li, 1, &ast Meng Ge, 2, &ast Jinlong Tian, 1, &ast Jinlei Zhou, 1, 3 Yao Kang, 1 Chen Xia, 1 Haiyu Shao, 1 Yongguang Wang, 4 Yazeng Huang, 1 Tingxiao Zhao 1 1 Center for Plastic & Reconstructive Surgery, Department of Orthopedics, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, People's Republic of China; 2 Department of Orthopedics, Hospital of Traditional Chinese Medicine of Xiaoshan District, Hangzhou, Zhejiang, People's Republic of China; 3 Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China; 4 Department of Orthopedics, Linping Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, Zhejiang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Tingxiao Zhao; Yazeng Huang, Center for Plastic & Reconstructive Surgery, Department of Orthopedics, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Shangtang Road 158&num, Hangzhou, Zhejiang, People's Republic of China, Email ; Purpose: Percutaneous endoscopic transforaminal lumbar interbody fusion (PE-TLIF) has become one of the most popular minimally invasive surgeries today. However, the issue of hidden blood loss (HBL) in this surgery has received little attention. This study aims to examine the HBL in PE-TLIF surgery and the effect of tranexamic acid (TXA) on blood loss. Methods: In our research, We conducted a retrospective analysis of 300 patients who underwent PE-TLIF from September 2019 to August 2023. They were divided into 2 groups based on whether they received intravenous TXA injection before surgery. The variables compared included: demographic data, pre-and postoperative hemoglobin (HB), hematocrit (HCT), platelets (PLT), red blood cells (RBC), total blood loss (TBL), visible blood loss (VBL), HBL, operation time, postoperative hospital stay, inflammatory markers, coagulation parameters, and adverse events. Results: Regarding demographic characteristics, besides the operation time, no significant differences were observed between the two groups. Compared with the control group, the TXA group showed a significant reduction trend in TBL, HBL, and VBL (P < 0.05). On the first day after surgery, there were significant differences in prothrombin (PT), activated partial thromboplastin time (APTT), and D-dimer (D-D) levels between the two groups. Similarly, HCT also found similar results on the third day after surgery. No adverse events occurred in either group. Conclusion: Research has found that there is a significant amount of HBL in patients undergoing PE-TLIF. Intravenous injection of TXA can safely and effectively reduce perioperative HBL and VBL. Additionally, compared to the control group, the TXA group shows a significant reduction in operation time. Keywords: percutaneous endoscopic transforaminal lumbar interbody fusion, tranexamic acid, total blood loss, visible blood loss, hidden blood loss With the increase in the aging population, the incidence of degenerative lumbar disease has been rising year by year. 1,2 PE-TLIF, due to its minimal trauma, fast recovery, and fewer complications, is widely used in the treatment of degenerative lumbar disease, particularly favored by middle-aged and elderly patients. 3–5 However, the bleeding situation of this minimally invasive surgery is often overlooked, especially HBL. The recent research 6 found that the HBL of endoscopic transforaminal lumbar interbody fusion (Endo-TLIF) can reach 91% of TBL, with an average of approximately 717.9 ± 220.1 mL. Similarly, Zhou L et al 7 found that the HBL during oblique lateral interbody fusion (OLIF) accounted for 92.4% of the TBL, averaging around 809.0 ± 358.8 mL. Massive HBL can increase the risk of infection, anemia, blood transfusion, and other complications, which significantly affect the speed of postoperative recovery, increase medical expenses, and even endanger the patient's life. 8 Therefore, finding effective ways to reduce HBL has become a major concern in PE-TLIF surgery. Tranexamic acid (TXA) is a synthetic analogue of lysine that reduces intraoperative bleeding by inhibiting plasminogen activation and blocking fibrinolysis. 9,10 At the same time, TXA also has certain anti-inflammatory effects and the ability to regulate the body's immune response. 11–13 Some studies have shown that TXA can effectively reduce blood loss and blood transf -Abstract Truncated-
health care sciences & services